The Catalyst, June 2023


The latest innovation news from the Oxford ecosystem.

Welcome to The Catalyst. In this edition we feature Beacon Therapeutics, a leading ophthalmic gene therapy company, securing a ground-breaking £96m seed investment to pioneer transformative gene therapies for retinal diseases, offering hope in restoring sight and shaping a brighter future.

View newsletter
Sparks Background Image

Ready to get in touch?

Contact Us
Sparks Background Image
© Oxford University Innovation